Eric Newman

Eric Newman serves as Vice President and Chief Financial Officer at Hemanext since 2018, focusing on developing advanced technology for red cell transfusion therapy. Prior to this, Eric held the position of Corporate Officer and Director of Finance for TEI Biosciences and TEI Medical at Integra LifeSciences from 2008 to 2017, where responsibilities included managing finance and tax operations and facilitating due diligence during the acquisition process. Eric's earlier experience includes serving as Director of Finance/Controller at PointCare Technologies from 2003 to 2008, as well as Controller/Director of Finance at Union Biometrica in 2000-2001. Eric holds a Bachelor of Science in Accountancy from Bentley University.